statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harvard Bioscience (HBIO) has provided an announcement. Harvard Bioscience, Inc.'s Compensation Committee has recently greenlit the 2024 annual cas...

Harvard Bioscience Sets Incentive Plan for Top Executives

HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at...

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

This is a Bullish indicator signaling HBIO's price could rise from here. Traders may explore going long the stock or buying call options...

Harvard Bioscience (HBIO, $4.4) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 8, 2024

Q4 2023 Harvard Bioscience Inc Earnings Call Transcript

Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation...

Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation

Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript...

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript

Harvard Bioscience (NASDAQ:HBIO) est cens e publier ses derniers b n fices ce jeudi. Voici l'opinion de Benzinga\ sur le rapport de r sultats quatri me trimestre de Harvard Bioscience.
R sultat net...

Panorama des b n fices de Harvard Bioscience

Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analyticsHOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience...

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

This price move could indicate a change in the trend, and may be a buy signal for investors...

Harvard Bioscience (HBIO, $4.89) price moved above its 50-day Moving Average on February 15, 2024

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Volume	60,745.00
52-Wk High	$6.29
52-Wk Low	$3.60

HBIO Harvard Bioscience Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals